$<sup>18</sup>F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib$

<sup>18</sup>F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib

Background: The tyrosine kinase inhibitor (TKI) Lenvatinib represents one of the most effective therapeutic options in patients with advanced radioiodine refractory differentiated thyroid carcinoma (DTC). We aimed to assess the role of 2-deoxy-2-[<sup>18</sup>F] fluoro-D-glucose positron...

Full description

Bibliographic Details
Main Authors:	Freba Ahmaddy, Caroline Burgard, Leonie Beyer, Viktoria Florentine Koehler, Peter Bartenstein, Matthias P. Fabritius, Thomas Geyer, Vera Wenter, Harun Ilhan, Christine Spitzweg, Andrei Todica
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Cancers
Subjects:	differentiated thyroid cancer radioiodine refractory Lenvatinib <sup>18</sup>F-FDG-PET/CT
Online Access:	https://www.mdpi.com/2072-6694/13/2/317

Similar Items

Course of Disease and Clinical Management of Patients with Poorly Differentiated Thyroid Carcinoma
by: Freba Grawe, et al.
Published: (2021-10-01)

Initial Evaluation of Therapy Response after Adjuvant Radioiodine Therapy in Patients with Early-Stage Papillary Thyroid Cancer—Does Time Matter?
by: Freba Grawe, et al.
Published: (2022-01-01)

Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
by: Urbano Anido Herranz
Published: (2022-10-01)

2-[<sup>18</sup>F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study
by: Stefano Gay, et al.
Published: (2022-02-01)

Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
by: Maaike Dotinga, et al.
Published: (2022-12-01)

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
by: Jaume Capdevila, et al.
Published: (2023-08-01)

Clinical use of lenvatinib in patients with previous renal and/or hepatic impairment and radioiodine‐refractory differentiated thyroid cancer
by: Javier Martínez‐Trufero
Published: (2022-10-01)

Genotoxicity Associated with <sup>131</sup>I and <sup>99m</sup>Tc Exposure in Nuclear Medicine Staff: A Physical and Biological Monitoring Study
by: Justyna Miszczyk, et al.
Published: (2022-05-01)

RADIOIODINE TREATMENT OF GRAVES’ DISEASE – DOSE/RESPONSE ANALYSIS
by: Jitka Čepková, et al.
Published: (2014-01-01)

Primary presentation and clinical course of pediatric and adolescent patients with differentiated thyroid carcinoma after radioiodine therapy
by: Caroline Burgard, et al.
Published: (2023-10-01)

Use of multikinase inhibitors/lenvatinib concomitant with antiresorptive therapy for bone metastases from radioiodine‐resistant differentiated thyroid cancer
by: Elena Navarro‐Gonzalez
Published: (2022-10-01)

Glutamate-Evoked Ca<sup>2+</sup> Responses in the Rat Suprachiasmatic Nucleus: Involvement of Na<sup>+</sup>/K<sup>+</sup>-ATPase and Na<sup>+</sup>/Ca<sup>2+</sup>-Exchanger
by: Pi-Cheng Cheng, et al.
Published: (2023-03-01)

Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen<sup>®</sup>, for the Radiolabeling of β-CIT with Iodine-131: Relevance for Parkinson’s Disease
by: Ana Claudia R. Durante, et al.
Published: (2019-02-01)

Heterotridentate Organomonophosphines in Pt(κ<sup>3</sup>–X<sup>1</sup>P<sup>1</sup>X<sup>2</sup>)(Y) (X<sup>1,2</sup> = N<sup>1,2</sup> or S<sup>1,2</sup>), Pt(κ<sup>3</sup>–P<sup>1</sup>N<sup>1</sup>X<sup>1</sup>)(Y) (X<sup>1</sup> = O, C, S or Se) Pt(κ<sup>3</sup>–P<sup>1</sup>S<sup>1</sup>Cl<sup>1</sup>)(Cl) and Pt(κ<sup>3</sup>–P<sup>1</sup>Si<sup>1</sup>N<sup>1</sup>)(OL)—Structural Aspects
by: Milan Melník, et al.
Published: (2022-12-01)

Na<sup>+</sup>,K<sup>+</sup>-ATPase with Disrupted Na<sup>+</sup> Binding Sites I and III Binds Na<sup>+</sup> with Increased Affinity at Site II and Undergoes Na<sup>+</sup>-Activated Phosphorylation with ATP
by: Hang N. Nielsen, et al.
Published: (2024-01-01)

Molecular Imaging with <sup>18</sup>F-FDG PET/CT and <sup>99m</sup>Tc-MIBI SPECT/CT in Osteitis Fibrosa Cystica Generalisata
by: Adrien Holzgreve, et al.
Published: (2021-07-01)

Organomonophosphines in Pt(η<sup>3</sup>-X<sup>1</sup>X<sup>2</sup>X<sup>3</sup>)(PR<sub>3</sub>), (X = N<sup>1</sup>, N<sup>2</sup>, N<sup>3</sup>; S<sup>1</sup>, S<sup>2</sup>, S<sup>3</sup>; or Te<sup>1</sup>, Te<sup>2</sup>, Te<sup>3</sup>) Derivatives: Structural Aspects
by: Milan Melník, et al.
Published: (2023-06-01)

The Pseudo-Protic Ionic Liquids TOAH<sup>+</sup>Cl<sup>−</sup> and TODAH<sup>+</sup>Cl<sup>−</sup> as Carriers for Facilitated Transport of In(III) from HCl Solutions
by: Francisco José Alguacil, et al.
Published: (2022-12-01)

Total Tumor Volume on <sup>18</sup>F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with <sup>225</sup>Ac-PSMA-I&T
by: Lena M. Unterrainer, et al.
Published: (2022-04-01)

Comparison of Flow and Compression Properties of Four Lactose-Based Co-Processed Excipients: Cellactose<sup>®</sup> 80, CombiLac<sup>®</sup>, MicroceLac<sup>®</sup> 100, and StarLac<sup>®</sup>
by: Martin Dominik, et al.
Published: (2021-09-01)

K<sup>+</sup> and Ca<sup>2+</sup> Channels Regulate Ca<sup>2+</sup> Signaling in Chondrocytes: An Illustrated Review
by: Yoshiaki Suzuki, et al.
Published: (2020-06-01)

Safranal Induces Vasorelaxation by Inhibiting Ca<sup>2+</sup> Influx and Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger in Isolated Rat Aortic Rings
by: Noor Nadhim Al-Saigh, et al.
Published: (2022-06-01)

Rare Earth Elements Geochemistry and <sup>234</sup>U/<sup>238</sup>U, <sup>235</sup>U/<sup>238</sup>U Isotope Ratios of the Kanyakumari Beach Placer Deposits: Occurrence and Provenance
by: Thennaarassan Natarajan, et al.
Published: (2023-06-01)

Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after <sup>177</sup>Lu-PSMA-617 Radioligand Therapy
by: Friederike Völter, et al.
Published: (2021-03-01)

Mitochondrial DNA tRNA<sup>Leu</sup> and tRNA<sup>Ser</sup> polymorphism in different pig breeds
by: M. A. Kolosova, et al.
Published: (2018-10-01)

Chemical Separation of Uranium and Precise Measurement of <sup>234</sup>U/<sup>238</sup>U and <sup>235</sup>U/<sup>238</sup>U Ratios in Soil Samples Using Multi Collector Inductively Coupled Plasma Mass Spectrometry
by: Nimelan Veerasamy, et al.
Published: (2020-05-01)

An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na<sup>+</sup>/I<sup>−</sup> Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells
by: Thoudam Debraj Singh, et al.
Published: (2023-02-01)

Meteoric <sup>10</sup>Be, <sup>137</sup>Cs and <sup>239+240</sup>Pu as Tracers of Long- and Medium-Term Soil Erosion—A Review
by: Aleksandra Loba, et al.
Published: (2022-03-01)

PET/CT with <sup>18</sup>F-choline or <sup>18</sup>F-FDG in Hepatocellular Carcinoma Submitted to <sup>90</sup>Y-TARE: A Real-World Study
by: Luca Filippi, et al.
Published: (2022-11-01)

Wound Repair and Ca<sup>2+</sup> Signalling Interplay: The Role of Ca<sup>2+</sup> Channels in Skin
by: Gregorio Bonsignore, et al.
Published: (2024-03-01)

Piezoelectric A<sup>15</sup>B<sup>16</sup>C<sup>17</sup> Compounds and Their Nanocomposites for Energy Harvesting and Sensors: A Review
by: Piotr Szperlich
Published: (2021-11-01)

Inhibition of Voltage-Gated Na<sup>+</sup> Currents Exerted by KB-R7943 (2-[2-[4-(4-nitrobenzyloxy)phenyl]ethyl]isothiourea), an Inhibitor of Na<sup>+</sup>-Ca<sup>2+</sup> Exchanging Process
by: Sheng-Nan Wu, et al.
Published: (2023-01-01)

Spinach Plants Favor the Absorption of K<sup>+</sup> over Na<sup>+</sup> Regardless of Salinity, and May Benefit from Na<sup>+</sup> When K<sup>+</sup> is Deficient in the Soil
by: Jorge F. S. Ferreira, et al.
Published: (2020-04-01)

Heat-Affected-Zone Liquation Cracking in Welded Cast Haynes<sup>®</sup> 282<sup>®</sup>
by: Sukhdeep Singh, et al.
Published: (2019-12-01)

Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with <sup>68</sup>Ga and <sup>177</sup>Lu as Potential Theranostic Agent for Colon Cancer
by: Radu Anton Leonte, et al.
Published: (2021-04-01)

Comparison of <sup>18</sup>F-FDG PET/CT and <sup>68</sup>Ga-FAPI in Spindle Cell Rhabdomyosarcoma
by: Zhihui Shen, et al.
Published: (2023-09-01)

<sup>7</sup>Be, <sup>210</sup>Pb<sub>atm</sub> and <sup>137</sup>Cs in Snow Deposits in the Arctic Part of Western Siberia (Yamal-Nenets Autonomous District)
by: Kseniya Mezina, et al.
Published: (2020-08-01)

The Reliability of ClinCheck<sup>®</sup> Accuracy before and after Invisalign<sup>®</sup> Treatment—A Multicenter Retrospective Study
by: Wafa Alswajy, et al.
Published: (2023-04-01)

CD3<sup>+</sup>, CD8<sup>+</sup>, CD4<sup>+</sup> and FOXP3<sup>+</sup> T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors
by: Niko Hiltunen, et al.
Published: (2021-06-01)

Compatible Stability and Aerosol Characteristics of Atrovent<sup>®</sup> (Ipratropium Bromide) Mixed with Salbutamol Sulfate, Terbutaline Sulfate, Budesonide, and Acetylcysteine
by: Yiting Chen, et al.
Published: (2020-08-01)